Atsushi Amano

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Prognostic Factors

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuo Terauchi, Takahiro Nakama, Robert Spranger, Atsushi Amano, Takahiro Inoue, Elisabeth Niemoeller
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicentre study: The LixiLan JP-O2 randomized clinical trial. Diabetes, obesity & metabolism (2021)
Yasuo Terauchi, Daisuke Yabe, Hideaki Kaneto, Atsushi Amano, Mike Baxter, Daisuke Watanabe, Hirotaka Watada, Nobuya Inagaki
Benefits of the fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time-to-control analysis of the LixiLan JP phase 3 trials. Diabetes, obesity & metabolism (2021)
Hideaki Kaneto, Akane Takami, Robert Spranger, Atsushi Amano, Daisuke Watanabe, Elisabeth Niemoeller
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L randomized clinical trial. Diabetes, obesity & metabolism (2021)